Contemporary nationwide patternsofactive surveillance use for prostate cancer

JAMA Internal Medicine

Volumn 175, Issue 9, 2015, Pages 1569-1571

  Maurice, Matthew J ^a,b   Abouassaly, Robert ^a   Kim, Simon P ^a   Zhu, Hui ^b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AFRICAN AMERICAN; CANCER EPIDEMIOLOGY; EDUCATIONAL STATUS; GLEASON SCORE; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; HEALTH SURVEY; PROSTATE TUMOR;

HUMANS; MALE; POPULATION SURVEILLANCE; PROSTATIC NEOPLASMS;

EID: 84941248823     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.2835     Document Type: Letter

References (6)

1. Sammon JD, Pucheril D, Diaz M, et al. Contemporary nationwide patterns of self-reported prostate-specific antigen screening. JAMA Intern Med. 2014;174(11):1839-1841.
2. Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011;29(27):3669-3676.
3. Thompson I, Thrasher JB, Aus G, et al; AUA Prostate Cancer Clinical Guideline Update Panel. Guidelineforthe management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106-2131.
4. Dall'Era MA, Albertsen PC, Bangma C, et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012;62(6):976-983.
5. Maurice MJ, Zhu H, Abouassaly R. A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United States. Can Urol Assoc J. 2015;9 (3-4):e193-e199. doi:10.5489/cuaj.2606.
6. Godtman RA, Holmberg E, Khatami A, Stranne J, Hugosson J. Outcome following active surveillance of men with screen-detected prostate cancer: results from the Göteborg randomised population-based prostate cancer screening trial. Eur Urol. 2013;63(1):101-107.